超越合同:来自欧洲生物分析论坛的Pharma-CRO合作原则
Philip Timmerman1, Matthew Barfield2, Lee Goodwin3
1European Bioanalysis Forum, Brussels, Belgium.
Bioanalysis
|November 6, 2025
概括
制药公司和合同研究组织之间的有效合作是药物开发的关键. 本研究概述了可靠合作伙伴关系的基本原则,改善沟通和项目成果,使患者受益.
科学领域:
- 药物开发 药物开发
- 制药行业 制药行业 制药行业
- 合同研究组织 合同研究组织
背景情况:
- 制药发展在很大程度上依赖于赞助商和合同研究组织 (CRO) 之间的合作.
- 常见的挑战包括沟通不良,期望不清晰,交易关系和功能孤岛,阻碍项目成功.
- 解决这些弱点对于有效的药物开发至关重要.
研究的目的:
- 确定并提出加强制药公司和CRO之间合作的原则.
- 改进针对不同项目阶段的沟通策略.
- 为了促进可持续的,长期的伙伴关系超越单纯的交易.
主要方法:
- 欧洲生物分析论坛的专门团队对合作问题的分析.
- 专注于沟通策略和建立可持续的伙伴关系.
- 通过社区对话在焦点研讨会和领导意见中验证和完善原则.
主要成果:
- 确定在药物开发中可靠合作所必需的关键原则.
- 强调适应性沟通和明确的期望设置.
- 从交易关系转向可持续伙伴关系的框架.
结论:
- 实施结构化原则可以显著提高制药-CRO合作的可靠性.
- 加强合作加速了科学进步,并使患者受益.
- 提出的原则是优化伙伴关系动态的基础.
相关概念视频
Biopharmaceutics and Pharmacokinetics: Overview
4.7K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
4.7K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
631
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
631
Bioavailability Study Design: Healthy Subjects Versus Patients
252
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
252
Bioequivalence studies: Biowaivers
433
In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
433
Drug Products: Biologics, Biosimilars and Interchangeables
370
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
370
Biopharmaceutical Factors Influencing Drug Product Design: Overview
561
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though...
561


